-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: business development
Venture Capital Trends
With industry data and numbers, results are always a mixed bag, says David Thomas, BIO’s Director of Industry Research & Analysis – and the latest on venture capital trends is no exception. In the U.S., biotech VC funding is flat, and start-up money is drying up. According to the National Venture Capital Association (NCVA), U.S. VC funding for biotech fell to $4.1 billion in 2012 (figure 1). This 17% drop was greater than the 10% Read More >
Finding Biotech in the Silicon Prairie
The Silicon Prairie is about more than technology companies and Internet start-ups. In fact, the biotech industry in Illinois employs nearly 80,000 people, according to a recent analysis by Battelle, and their salaries are double the salary of the average private sector worker in the state. As biotech executives from across the globe descend upon McCormick Place this week for the annual BIO International Convention, they will have an opportunity to see that the Chicago Read More >
BIO One-On-One Partnering Kicks Off!
Partnering kicked off this today at the Business Forum at the 2013 BIO International Convention, and the numbers so far show that we have a strong week ahead of us. Over 130,000 partnering meeting requests have been requested Almost 22,000 meetings are already scheduled 4,900 of those meetings are exhibitor partnering meetings For a more in-depth look at the types of companies being represented at and stats on how many partnering meetings are taking place, check out this interview with Read More >
Opening Up Innovation
Open Innovation has become a major theme in the life sciences over the last couple of years. Most of the attention has focused on initiatives where big pharma offers access to non-core assets to outside researchers in the hope that they will develop them successfully or form collaborations. In Sweden, AstraZeneca have followed this path, but interest in the concept has spread further down the discovery chain, generating creative initiatives from universities, tech transfer organizations, Read More >
Crowdfunding Goes Viral
Is crowdfunding a viable source of capital for biotech companies? μBiome thinks so; they are a startup biotech company that raised $351,193. They asked for $100,000. That’s right; over three times their goal. “[Crowdfunding for biotech] is an idea whose time has come,” says μBiome’s CEO Jessica Richman. “The fact that we did it is proof of that. We’re the first ones but there will be lots of others.” Is there a way that crowdfunding could help Read More >
